CareDx

CDNA64

$24.11arrow_drop_up4.15%$0.96

CDNA64

$24.11

arrow_drop_up4.15%$0.96

Performance History

Key Stats
Open	$23.28
Prev. Close	$23.13
EPS	-2.69
Dividend	Non-Dividend
Next Earnings Date	-
Dividend Yield %	-

PE Ratio	-

	LOW	HIGH
Day Range	23.03	24.35
52 Week Range	4.80	34.84

Ratios







EPS	-2.69

Score Breakdown

Welcome to Stocklytics

Don't miss out on the opportunity to stay ahead in the ever-changing world of finance.

Analyst Forecast

Period: Next 12 Months

•

Analyst Ratings

•

About CareDx (CDNA)

CareDx Inc (CDNA) is a biotechnology company that specializes in molecular diagnostics for transplant patients. The company develops, markets, and sells diagnostic tests for transplantation through its proprietary platform, AlloSure. AlloSure is a non-invasive blood test that measures donor-derived cell-free DNA (ddcfDNA) in transplant recipients. This test provides actionable information to clinicians to detect organ rejection and optimize immunosuppression therapy. With its innovative technology, CareDx is revolutionizing the way transplant patients are monitored and managed.

With a rich history of stock price performance, CareDx Inc has shown consistent growth and impressive returns for its investors. The company's stock has been on an upward trajectory, with a significant increase in value over the past few years. As of the latest available data, CDNA stock is trading at $80.50 per share, with a market capitalization of $4.5 billion. This places the company among the top players in the biotechnology industry.

Websitecall_made

Sector: Healthcare
Industry: Diagnostics & Research
CEO: Dr. Reginald Seeto M.D., MBBS
Headquarters: South San Francisco
Employees: 727
Exchange: NASDAQ

Keep an eye on CareDx

Adding the right stocks to your watchlist can provide valuable insights and opportunities for strategic decision-making.

Frequently Asked Questions

help

What is CareDx 's (CDNA) price per share?

The current price per share for CareDx (CDNA) is $24.11. The stock has seen a price change of $0.96 recently, indicating a 4.15% change. This reflects the stock's recent market performance and investor sentiment.

help

What is the 52-week high and low for CareDx (CDNA)?

For CareDx (CDNA), the 52-week high is $34.84, which is 44.5% from the current price. The 52-week low is $4.8, the current price is 402.29% above the 52-week low. This gives investors an insight into the stock's volatility and price range over the past year.

help

Is CareDx (CDNA) a growth stock?

CareDx (CDNA) has shown an average price growth of -3.36% over the past three years. It has received a score of 68 out of 100 based on the Stocklytics formula. The interpretation of this score in terms of classifying CareDx as a growth stock may vary, considering it is one of many factors investors might evaluate, including market trends, financial performance, and future prospects of the company.

help

What is CareDx (CDNA) stock price performance year to date (YTD)?

As of the latest data, CareDx (CDNA) has a year-to-date price change of 101.93%. Over the past month, the stock has experienced a price change of 7.68%. Over the last three months, the change has been -24.33%. Over the past six months, the figure is 49.29%. Looking at a longer horizon, the five-year price change stands at 17.32%.

help

Is CareDx (CDNA) a profitable company?

CareDx (CDNA) has a net income of -$190.28M, which represents the company's total earnings after all expenses have been deducted from revenues. The gross margin of 63.61% indicates the percentage of revenue that exceeds the cost of goods sold, and the operating margin of -12.66% reflects the percentage of revenue remaining after covering variable production costs, highlighting the efficiency of the company's core operations. Total revenue stands at $280.32M, although specific revenue growth data is currently not available. The gross profit is $178.32M. Operating income is noted at -$101.9M. Furthermore, the EBITDA is $13.69M.

help

What is the market capitalization of CareDx (CDNA)?

CareDx (CDNA) has a market capitalization of $1.29B. The average daily trading volume is 23.82, indicating the stock's liquidity and investor engagement.

News

CAREDX, INC.

PUERTO RICO RESIDENTS TAX-FREE FUND, INC.

PUERTO RICO RESIDENTS TAX-FREE FUND VI, INC.

TAX FREE FUND FOR PUERTO RICO RESIDENTS, INC.

Sep 24, 2024

ALERTA PARA LOS ACCIONISTAS: Morris Kandinov investiga a CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., y Tax Free Fund for Puerto Rico Residents, Inc.; se anima a los accionistas a ponerse en contacto con la firma

CAREDX

PUERTO RICO RESIDENTS TAX-FREE FUND

PUERTO RICO RESIDENTS TAX-FREE FUND VI

TAX FREE FUND FOR PUERTO RICO RESIDENTS

Sep 24, 2024

SHAREHOLDER ALERT: Morris Kandinov Investigating CareDx, Inc., Puerto Rico Residents Tax-Free Fund, Inc., Puerto Rico Residents Tax-Free Fund VI, Inc., and Tax Free Fund for Puerto Rico Residents, Inc.; Shareholders are Encouraged to Contact the Firm

LIQUID BIOPSY

CANCER DIAGNOSTICS

NEXT-GENERATION SEQUENCING

NORTH AMERICA

MARKET GROWTH

Sep 13, 2024

Liquid Biopsy Market to Reach $ 32.54 Billion, Globally, by 2033 at 11.61% CAGR: The Brainy Insights

LABORATORY-DEVELOPED TESTS

LDTS

FDA REGULATIONS

CLINICAL LABORATORIES

DIAGNOSTIC SERVICES

DIAGNOSTIC PRODUCTS

Aug 15, 2024

Laboratory-Developed Tests (LDTs) World Market Forecast Report to 2028, with Coverage of the Effects of the FDA's New "Medical Devices: Laboratory Developed Tests" Rule, Passed in April 2024

CAREDX

ANALYST RATINGS

FINANCIAL PERFORMANCE

Jul 17, 2024

Where CareDx Stands With Analysts - Benzinga

ANALYST RATINGS

May 31, 2024

Decoding 6 Analyst Evaluations For CareDx